Ono Pharmaceutical Co., Ltd.
Notice on Payment Completion for Share Buyback as Part of Employee Stock-based Compensation and Performance-based Restricted Stock Compensation
Payment completion of treasury stock for employee stock-based compensation and performance-based restricted stock compensation. The number of disposed shares is approximate, allocated to internal directors. A separate document discloses payment date, share count, and price.
Key Figures
- Disposal shares (employee stock-based compensation): 20,900 shares
- Disposal shares (performance-based compensation): 179,000 shares
- Disposal price: 2,249.5 yen per share
AI要約
Overview
Today, as of July 10, 2026, payment procedures for the disposition of treasury stock as part of employee stock-based compensation and performance-based restricted stock compensation based on the board of directors’ resolution on June 18, 2026, have been completed. Payment date is the same day. The disposals are potentially to total over 270,000 shares, allocated to three internal directors and 12–13 executive officers who do not concurrently serve as directors, though the breakdown of executives is included in the text.
Impact and Outlook
The disposal of treasury stock is conducted as part of the remuneration system, and its impact on shareholder value depends on the number of disposed shares and price per share. The disposal price is 2,249.5 yen per share, and the total amount is referenced in related materials. The move appears aimed at enhancing transparency of internal compensation systems and strengthening human incentives. Future disclosure trends and assessments of impact on shareholders will require reference to the detailed materials already issued.
Ono Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR